Navigation Links
NSF awards 14 materials research science and engineering centers
Date:10/2/2008

The National Science Foundation (NSF) announces 14 Materials Research Science and Engineering Centers (MRSECs) awarded as a result of the 2008 MRSEC competition (solicitation NSF 07-563).

MRSECs support outstanding multi- and inter-disciplinary materials research and education addressing fundamental problems in science and engineering. These centers investigate complex problems that benefit from the scope and level of interactions provided by a center. They foster active collaboration among universities, other MRSECs, industry, and National Laboratories.

"We are delighted to fund 14 MRSECs including five new centers," said Zakya H. Kafafi, director for NSF's Division of Materials Research (DMR). "These centers will promote the progress of materials science and education in important and timely areas such as sustainable energy, bio- and soft-materials and, next-generation electronics and photonics. In this regard, MRSECs will help further our economic competitiveness and our ability to live sustainably on earth, and will contribute to DMR's efforts of broadening participation, and bridging the gaps in materials education between different institutions at all levels."

The MRSECs are committed to broadening participation of underrepresented groups in materials research and education at all academic levels, and actively seek partnerships with schools, universities and colleges serving these groups which include women, minorities and people with disabilities.

Five new MRSECs were created as a result of the competition:

  • The Renewable Energy Materials Research Science and Engineering Center at the Colorado School of Mines will study the unique properties of nanostructured materials to significantly enhance the performance of semiconductor photovoltaic devices and ion conducting composite membrane materials for fuel cells.

  • The Georgia Tech Laboratory for New Electronic Materials at the Georgia Institute
    '/>"/>

Contact: Bobbie Mixon
bmixon@nsf.gov
703-292-8485
National Science Foundation
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
2. First Program Addressing Aircraft Industry Sustainability Awards Accreditation To Five Global Companies
3. DARPA awards research team $1.2M grant to study surface enhanced Raman scattering
4. Argonne researchers win 2 R&D 100 Awards
5. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
6. EnterPrize Business Plan Competition Announces Final Phase Winners of Cash Awards Totaling $45,000
7. Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards
8. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
9. Advance Nanotechs Owlstone Subsidiary Selected as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition
10. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
11. Cadient Group Brings Home the Gold at 2008 Aster Awards
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 1CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 3CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 4CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 5CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 6CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 7CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 9CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 10CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 11CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 12CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 13CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 14CryoLife Reports Record Quarterly Revenues of 2428 2 Million 5824 15Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 1Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 2Global Spinal Nonfusion Market to Reach Almost 242 Billion By 2013 According to Millennium Research Group 5822 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 1Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 2Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 4Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 5Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 6Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 7Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 8Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 9Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 10Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 11Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 12Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 13Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 14Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 15